UPDATE: Piper Sandler Upgrades Amphastar Pharmaceuticals (AMPH) to Overweight
Tweet Send to a Friend
(Updated - January 7, 2022 4:41 AM EST)
Piper Sandler analyst David Amsellem upgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem upgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
